Document Detail

Sirolimus-eluting and paclitaxel-eluting stents for the treatment of coronary bifurcations.
MedLine Citation:
PMID:  18946894     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: The aim of the study was to compare the outcomes of sirolimus-eluting (SES) and paclitaxel-eluting (PES) stent implantation in coronary bifurcations treated with either a 1-stent or 2-stent strategy. METHODS: The study used a retrospective cohort analysis of consecutive de novo bifurcations, excluding left main, treated with SES or PES between April 2003 and June 2005. RESULTS: We identified 170 bifurcations in 161 patients treated with SES and 119 bifurcations in 112 patients treated with PES. During a median follow-up of 1,061 days (interquartile range 814-1,314), 43 patients (26.7%) in the SES group and 28 (25.0%) in the PES group had a major adverse cardiac event (P = .78). The angiographic restenosis rate per bifurcation was 20.9% and 25.9%, respectively (P = .41). There was no difference overall in the occurrence of target lesion revascularization (TLR) per bifurcation, 22 with SES (12.9%) and 18 with PES (15.1%), P = .61. The TLR rate was similar for SES and PES in bifurcations treated with 1 stent (6.7% vs 11.4%, P = .40) and in bifurcations treated with both branch stenting (20.0% vs 20.4%, P =1.0). CONCLUSIONS: In this cohort, the long-term clinical outcomes appear similar overall between SES and PES in the treatment of coronary bifurcations irrespective of whether a 1-stent or 2-stent strategy was used.
Azeem Latib; John Cosgrave; Cosmo Godino; Asif Qasim; Simon J Corbett; Davide Tavano; Nuccia Morici; Nicole Cristell; Alaide Chieffo; Mauro Carlino; Matteo Montorfano; Flavio Airoldi; Antonio Colombo
Related Documents :
11108324 - Coronary angioplasty and stenting in orthotopic heart transplants: a fruitful act or a ...
20527634 - Percutaneous coronary intervention for chronic total coronary occlusion in patients at ...
10695104 - Risk factor modification extends the benefit of coronary artery revascularisation proce...
15320854 - Inflammation and coronary artery disease.
21570254 - Early changes in left ventricular long-axis function in friedreich ataxia: relation wit...
8352184 - Clinical and hemodynamic predictors of survival in patients aged < 65 years with severe...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  American heart journal     Volume:  156     ISSN:  1097-6744     ISO Abbreviation:  Am. Heart J.     Publication Date:  2008 Oct 
Date Detail:
Created Date:  2008-10-22     Completed Date:  2008-11-14     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0370465     Medline TA:  Am Heart J     Country:  United States    
Other Details:
Languages:  eng     Pagination:  745-50     Citation Subset:  AIM; IM    
Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angioplasty, Transluminal, Percutaneous Coronary*
Coronary Angiography
Coronary Disease / radiography,  therapy*
Drug-Eluting Stents*
Immunosuppressive Agents / administration & dosage*
Middle Aged
Paclitaxel / administration & dosage*
Retrospective Studies
Sirolimus / administration & dosage*
Treatment Outcome
Reg. No./Substance:
0/Immunosuppressive Agents; 33069-62-4/Paclitaxel; 53123-88-9/Sirolimus

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effects of disclosing financial interests on participation in medical research: a randomized vignett...
Next Document:  Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque A...